Delivery Order SPE2DB22D3010-SPE2DB25FP2QS

Award Date 6/5/25
Potential Completion Date 6/6/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Budesonide-Formoterol 80-4.5 10.2GM, a pharmaceutical product. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on May 13, 2025, with a ceiling value of $1,214.16. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of May 14, 2025. This award is not associated with a...
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Budesonide-Formoterol 160-4.5 10.2GM medication. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and has a firm fixed price ceiling value of $2,090.40. The award is a delivery order with a period of performance through May 15, 2025. This contract is not set aside and represents open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order with a firm fixed price valued at $2,921.57. The award is for the procurement of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product, with a completion date of February 6, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This federal contract award is for the delivery of budesonide-formoterol 160-4.5 10.2GM pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a firm fixed price of $4,586.62. The award has an ultimate completion date of May 21, 2025. This contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of budesonide-formoterol 160-4.5 10.2GM. The contract is a delivery order with a firm fixed price of $3,840.42 and has an ultimate completion date of November 25, 2024. The contracting agency is the Defense Logistics Agency (DLA), a defense agency responsible for providing logistics, acquisition, and technical services to the U.S. Armed Forces....
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of budesonide-formoterol 160-4.5 10.2GM medical products. The contract has a fixed-price, delivery order structure with a ceiling value of $1,769.78 and a completion date of July 25, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product, with an ultimate completion date of January 9, 2025 and a ceiling value of $1,556.92. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with a specific set-aside...
This federal contract award is for the delivery of Budesonide-Formoterol 80-4.5 10.2GM pharmaceutical products to the Defense Logistics Agency (DLA). The contract, valued at $1,590.90, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Budesonide-Formoterol 80-4.5 10.2 GM, a pharmaceutical product, with a ceiling value of $3,540.00 and an ultimate completion date of November 21, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the...
This federal contract award is for the delivery of the pharmaceutical product Budesonide-Formoterol 160-4.5 10.2GM, with a ceiling value of $1,880.36. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary...
  • SPE2DB22D3010
    Indefinite Delivery Contract
  • SPE2DB22D3010-SPE2DB25FP2QS
    Delivery Order

This federal contract award is for the delivery of Budesonide-Formoterol 160-4.5 10.2GM pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $1,148.88 and is a Firm Fixed Price Delivery Order, with an ultimate completion date of June 6, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This award enables Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

Generated 9/4/25, 10:08 AM